Xiao-Chai-Hu Tang in treating model mice with D-galactosamine-induced liver injury

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 9, Issue 3, 2012, Pages 405-411

  Zhou, Yun Xiao ^a   Qiu, Yun Qing ^a   Xu, Li Qian ^a   Guo, Jing ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Chinese medicine formula; Liver injury; Xiao Chai Hu Tang(XCHT)

Indexed keywords

BIPHENYL DICARBOXYLATE; DICARBOXYLIC ACID DERIVATIVE; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 6; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XIAO CHAI HU TANG; BCL2 PROTEIN, MOUSE; FAS PROTEIN, MOUSE; GALACTOSAMINE; HERBACEOUS AGENT; SHOSAIKO-TO; XIAOCHAIHU TANG; XIAOCHAIHU-TANG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; LIVER INJURY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; UPREGULATION; WESTERN BLOTTING; ANGIOSPERM; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; GENETICS; LIVER; METABOLISM; PHYTOTHERAPY; CHINESE MEDICINE FORMULA; TOXIC HEPATITIS; XIAO-CHAI-HU TANG(XCHT);

ANGIOSPERMS; ANIMALS; ANTIGENS, CD95; BCL-2-ASSOCIATED X PROTEIN; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; GALACTOSAMINE; INTERLEUKIN-6; LIVER; MICE; PHYTOTHERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR NECROSIS FACTOR-ALPHA;

CHINESE MEDICINE FORMULA; LIVER INJURY; XIAO-CHAI-HU TANG(XCHT);

EID: 84896059767     PISSN: None     EISSN: 01896016     Source Type: Journal    
DOI: 10.4314/ajtcam.v9i3.16     Document Type: Article

References (7)

1. Chen, N.L., Gu, F. and Jia, K.M. Chronic active hepatitis with superinfection of delta virus and hepatitis B virus: treatment with Chinese traditional medicine. Zhonghua Nei Ke Za Zhi. 1990;29(3):144-146, 189.
2. Chen, F.P., Chen, F.J., Jong, M.S., Tsai, H.L., Wang, J.R. and Hwang, S.J., (2009). Modern use of Chinese herbal formulae from Shang-Han Lun. Chin Med J (Engl). 122(16):1889-1894.
3. Kaneko, M., Kawakita, T., Tauchi, Y., Saito, Y., Suzuki, A. and Nomoto, K., (1994). Augmentation of NK activity after oral administration of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to). Immunopharmacol and Immunotoxicol. 16(1):41-53.
4. Kusunose, M., Qiu, B., Cui, T., Hamada, A., Yoshioka, S., Ono, M., Miyamura, M., Kyotani, S. and Nishioka, Y., (2002). Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats. Biol Pharm Bull. 25(11):1417-1421.
5. Nishimura, N., Uemura, T., Iwamoto, K. and Naora, K., (2010). Change in tolbutamide permeability in rat jejunum and Caco-2 cells by Sho-saiko-to (Xiao Chai Hu Tang), a Chinese traditional medicine. J Pharm Pharmacol. 62(5):651-657.
6. Yamamoto, S., Oka, H., Kanno, T., Mizoguchi, Y. and Kobayashi, K., (1989). Controlled prospective trial to evaluate Syosakiko-to in preventing hepatocellular carcinoma in patients with cirrhosis of the liver. Gan To Kagaku Ryoho. 16(4 Pt 2-2):1519-1524.
7. Yamashiki, M., Asakawa, M., Kayaba, Y., Kosaka, Y. and Nishimura, A., (1992). Herbal medicine "sho-saiko-to" induces in vitro granulocyte colony-stimulating factor production on peripheral blood mononuclear cells. J Clin Lab Immunol. 37(2):83-90.